The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
April 17th 2024
Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Social Epidemiology of Diabetes
June 11th 2012Diabetes is a condition that has many variables. Researchers are finding more and more about how genetics and patient behavior play a role; however, it turns out that socioeconomic status, education, and ethnic background all play a role as well.
Read More
Altshuler Receives Outstanding Scientific Achievement Award for Diabetes-Based Genetics Research
June 11th 2012Monday morning at the ADA's 72nd Scientific Sessions featured the National Scientific & Health Care Achievement Awards Presentation and Outstanding Scientific Achievement Award Lecture. This year's recipient of the Outstanding Scientific Achievement Award was David Altshuler, MD, PhD, Professor of Medicine and Genetics at Harvard Medical School and Massachusetts General Hospital, Boston, for his work on genetic-based research regarding the inherited basis of type 2 diabetes, cholesterol levels, myocardial infarction, and a number of other conditions.
Read More
VIDEO: Margaret Powers, PhD, RD, CDE, Discusses the Effect Genetic Testing Has on Behavioral Change
June 10th 2012Dr. Margaret Powers says that currently genetic testing does not motivate behavior change and weight loss in diabetes care. Patients who did not receive the test did just as well with behavior changes as patients who knew they were high risk through genetic testing.
Read More
Evidence-Based Behavioral Interventions to Improve Medication Adherence
June 9th 2012Medication adherence is a complex topic that involves many barriers and obstacles; however, as Elizabeth A. Walker, PhD, RN, CDE, Director of the Prevention and Control Core, Einstein Diabetes Research and Training Center, Albert Einstein College of Medicine, Bronx, New York, told her audience at this year's ADA 72nd Scientific Sessions, we must do something.
Read More
Genetic Testing Shines Light on Diabetes-Related Complications
June 9th 2012As a new era of personalized medicine continues to provide clues between genetic makeups and predispositions to certain disease states, researchers and providers are able to come up with more targeted therapies for patient populations.
Read More
New Strategies in Diabetes Medication Adherence
June 9th 2012Medication adherence represents a major barrier to optimal therapeutic outcomes for a number of chronic conditions, and diabetes is no different. Often times, diabetes patients with poor glycemic control and multiple comorbidities have complex medication regimens, which often times complicate and exacerbate this problem.
Read More
Real-World Outcomes of Initiating Injectable Therapies in Type 2 Diabetes Patients
June 8th 2012To date, there has been no real-world comparative data published on the initiation of injectable therapy with insulin glargine disposable pen (GLA-P) of glucagons-like peptide-1 agonist liraglutide (LIRA) among type 2 diabetes patients. On day 1 of the American Diabetes Association's 72nd Scientific Sessions in Philadelphia, PA, an abstract was released by Levin et al which provided data from this exact comparative analysis.
Read More
Reining in Diabetes-Related Costs
June 8th 2012Diabetes is a chronic condition that has been shown to be directly related to obesity and heart-related conditions. The strain that diabetes costs put on the healthcare system are well documented. At this year's 72nd Scientific Sessions, the American Diabetes Association featured several studies that aim to help rein in diabetes costs. Here are two studies that were highlighted.
Read More
Predicting Costs With Diabetes Complications Severity Index in Claims Data
The Diabetes Complications Severity Index without laboratory test results is a good measure of diabetes severity, given its ability to explain costs.
Read More
Care by Cell Phone: Text Messaging for Chronic Disease Management
Cell phone“based text messaging may be used to feasibly support chronic disease management and engagement in diabetes self-care behaviors for some patients.
Read More
Nurse-Run, Telephone-Based Outreach to Improve Lipids in People With Diabetes
Nurses can improve lipid control in people with diabetes in a primarily indigent population through telephone care using moderately complex algorithms. Telephone-based outreach may decrease resource utilization.
Read More
Preventive Care and Health Behaviors Among Overweight/Obese Men in HMOs
Healthcare organizations may reduce weight-related health risks and disparities in care among overweight/obese patients through promoting cancer screening exams, healthier diets, and physical activity.
Read More